DANIEL HAMSTRA to Cisplatin
This is a "connection" page, showing publications DANIEL HAMSTRA has written about Cisplatin.
Connection Strength
0.495
-
Pharmacokinetic analysis and phase 1 study of MRX-1024 in patients treated with radiation therapy with or without cisplatinum for head and neck cancer. Clin Cancer Res. 2010 May 01; 16(9):2666-76.
Score: 0.316
-
Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer. Head Neck. 2018 07; 40(7):1375-1388.
Score: 0.136
-
Oral D-methionine protects against cisplatin-induced hearing loss in humans: phase 2 randomized clinical trial in India. Int J Audiol. 2022 08; 61(8):621-631.
Score: 0.044